Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during study day two
Awards & highlights
Study Summary
This trial aims to understand the effects of walking impairments on stroke survivors and create personalized treatments to help reduce fall risk.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during study day one
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during study day one
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Angular momentum during walking
Correlation between angular momentum and step length asymmetry during walking
Correlation between oxygen consumption (VO2) and step length asymmetry
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Post-stroke ParticipantsExperimental Treatment1 Intervention
The investigators will determine how different patterns of coordination during walking influence energetic cost and dynamic balance in people post-stroke. The investigators will manipulate coordination using a special treadmill. Energetic cost will be quantified using expired gas analysis and inverse dynamic approaches. Stability will be evaluated by characterizing participants' ability to recover from unexpected perturbations.
Group II: Healthy ParticipantsExperimental Treatment1 Intervention
The investigators will determine how asymmetric walking constraints influence spatiotemporal coordination, energetic cost, and dynamic balance in healthy individuals. The investigators will manipulate spatiotemporal coordination using a special treadmill. Energetic cost will be quantified using expired gas analysis and inverse dynamic approaches. Stability will be evaluated by characterizing participants' ability to recover from unexpected perturbations.
Find a Location
Who is running the clinical trial?
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,674,633 Total Patients Enrolled
79 Trials studying Stroke
5,279 Patients Enrolled for Stroke
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,170 Total Patients Enrolled
22 Trials studying Stroke
4,960 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a single stroke that caused a brain lesion on one side of your brain.You experience weakness on only one side of your body.You need to have good memory and thinking skills, which will be tested using a score called Mini-Mental.You need to score higher than 24 on a test that measures your memory and thinking skills (called Mini-Mental score).You don't have any injuries or conditions that make it difficult for you to walk.You have never had a serious head injury or neurological disorder.Requirements for people who have had a stroke to participate in the study.You can walk on a treadmill for five minutes without using a cane or walker.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Participants
- Group 2: Post-stroke Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger